Sleep plays a role in cognitive processes such as memory processing, attention processing, and overall cognitive function. In recent years, the bidirectional relationship between sleep loss and aging, as well as related neurodegenerative diseases, has garnered widespread attention. Sleep disorders are a typical clinical manifestation of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease and are closely related to the progression of these diseases. However, current research has yet to fully elucidate the physiological responses to sleep loss across different ages and cognitive levels, as well as the association and molecular basis between sleep loss, aging, and neurodegenerative diseases. This study aims to comprehensively characterize the transcriptional and metabolic changes in peripheral blood under sleep loss in populations of different ages and cognitive levels using multi-omics approaches and to preliminarily explore the role of sleep loss in aging and AD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hamilton Anxiety Rating Scale (HAM-A)
Timeframe: through study completion, an average of 1 month
Hamilton Depression Rating Scale (HDRS)
Timeframe: through study completion, an average of 1 month
Mini-Mental State Examination (MMSE)
Timeframe: through study completion, an average of 1 month
Montreal Cognitive Assessment (MoCA)
Timeframe: through study completion, an average of 1 month
Transcriptomic profile
Timeframe: through study completion, an average of 1 month
Metabolic profiling
Timeframe: through study completion, an average of 1 month
Self reported scales
Timeframe: through study completion, an average of 1 year